Martí Català

1.3k total citations · 1 hit paper
47 papers, 481 citations indexed

About

Martí Català is a scholar working on Infectious Diseases, Modeling and Simulation and Epidemiology. According to data from OpenAlex, Martí Català has authored 47 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 13 papers in Modeling and Simulation and 10 papers in Epidemiology. Recurrent topics in Martí Català's work include COVID-19 epidemiological studies (13 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and COVID-19 Clinical Research Studies (12 papers). Martí Català is often cited by papers focused on COVID-19 epidemiological studies (13 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and COVID-19 Clinical Research Studies (12 papers). Martí Català collaborates with scholars based in Spain, United Kingdom and Netherlands. Martí Català's co-authors include Clara Prats, Père-Joan Cardona, Sergio Alonso, Enrique Álvarez-Lacalle, Daniel Prieto‐Alhambra, Daniel López, Annika M. Jödicke, Antonella Delmestri, Talita Duarte‐Salles and Nhung TH Trinh and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Martí Català

42 papers receiving 476 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia

2024 84 citations Martí Català, Raivo Kolde et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martí Català Spain	14	261	111	101	76	50	47	481
Yifei Guo China	7	302 1.2×	134 1.2×	82 0.8×	95 1.3×	26 0.5×	20	491
Farzin Vahedi Iran	13	285 1.1×	58 0.5×	86 0.9×	82 1.1×	54 1.1×	19	599
Efrén Murillo‐Zamora Mexico	15	293 1.1×	59 0.5×	69 0.7×	83 1.1×	39 0.8×	82	563
Saurabh Zalpuri Netherlands	14	246 0.9×	63 0.6×	107 1.1×	115 1.5×	50 1.0×	20	898
Caifang Zheng China	5	296 1.1×	88 0.8×	63 0.6×	48 0.6×	167 3.3×	9	478
Pei Hua Lee Singapore	7	401 1.5×	78 0.7×	67 0.7×	69 0.9×	26 0.5×	13	515
Paul G. Carty Ireland	8	502 1.9×	130 1.2×	61 0.6×	72 0.9×	22 0.4×	14	646
Sojung Yoon South Korea	5	178 0.7×	116 1.0×	45 0.4×	28 0.4×	22 0.4×	10	317
Arjun Puranik United States	13	555 2.1×	57 0.5×	144 1.4×	75 1.0×	123 2.5×	22	703
Hira Imeri Switzerland	6	453 1.7×	332 3.0×	67 0.7×	94 1.2×	41 0.8×	7	710

Countries citing papers authored by Martí Català

Since Specialization

Citations

This map shows the geographic impact of Martí Català's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martí Català with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martí Català more than expected).

Fields of papers citing papers by Martí Català

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martí Català. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martí Català. The network helps show where Martí Català may publish in the future.

Co-authorship network of co-authors of Martí Català

This figure shows the co-authorship network connecting the top 25 collaborators of Martí Català. A scholar is included among the top collaborators of Martí Català based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martí Català. Martí Català is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Català, Martí, Edward Burn, Katia Verhamme, et al.. (2025). Secular Trends in the Use of Valproate‐Containing Medicines in Women of Childbearing Age in Europe: A Multinational DARWIN EU Network Study. Pharmacoepidemiology and Drug Safety. 34(10). e70232–e70232.

Xie, Junqing, Danielle Newby, Clara Prats, et al.. (2024). Effect of genetically predicted sclerostin on cardiovascular biomarkers, risk factors, and disease outcomes. Nature Communications. 15(1). 9832–9832. 4 indexed citations

Li, Xintong, Raivo Kolde, Nhung TH Trinh, et al.. (2024). The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications. Heart. 110(9). 635–643. 20 indexed citations

Guo, Yuchen, Victoria Y. Strauss, Martí Català, et al.. (2024). Machine learning methods for propensity and disease risk score estimation in high-dimensional data: a plasmode simulation and real-world data cohort analysis. Frontiers in Pharmacology. 15. 1395707–1395707. 2 indexed citations

Alonso, Sergio, Cristina Andrés, Andrés Antón, et al.. (2024). Mathematical modeling of SARS-CoV-2 variant substitutions in European countries: transmission dynamics and epidemiological insights. Frontiers in Public Health. 12. 1339267–1339267. 1 indexed citations

Català, Martí, et al.. (2024). Genome-wide association studies of COVID-19 vaccine seroconversion and breakthrough outcomes in UK Biobank. Nature Communications. 15(1). 8739–8739. 2 indexed citations

Català, Martí, Cristina Cano, Daniel López, et al.. (2024). Country-report pattern corrections of new cases allow accurate 2-week predictions of COVID-19 evolution with the Gompertz model. Scientific Reports. 14(1). 10775–10775. 4 indexed citations

Raventós, Berta, Martí Català, Yuchen Guo, et al.. (2023). IncidencePrevalence: An R package to calculate population‐level incidence rates and prevalence using theOMOPcommon data model. Pharmacoepidemiology and Drug Safety. 33(1). e5717–e5717. 8 indexed citations

Kostka, Kristin, Elena Roel, Nhung TH Trinh, et al.. (2023). The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis. Nature Communications. 14(1). 7449–7449. 9 indexed citations

10.

Murillo, Marta, María Pilar Armengol, Martí Català, et al.. (2023). Immunoregulatory Biomarkers of the Remission Phase in Type 1 Diabetes: miR-30d-5p Modulates PD-1 Expression and Regulatory T Cell Expansion. Non-Coding RNA. 9(2). 17–17. 4 indexed citations

11.

Coma, Ermengol, Martí Català, Leonardo Méndez-Boo, et al.. (2022). Unravelling the role of the mandatory use of face covering masks for the control of SARS-CoV-2 in schools: a quasi-experimental study nested in a population-based cohort in Catalonia (Spain). Archives of Disease in Childhood. 108(2). 131–136. 18 indexed citations

12.

Català, Martí, Ermengol Coma, Sergio Alonso, et al.. (2022). Transmissibility, hospitalization, and intensive care admissions due to omicron compared to delta variants of SARS-CoV-2 in Catalonia: A cohort study and ecological analysis. Frontiers in Public Health. 10. 961030–961030. 14 indexed citations

13.

Sepúlveda, María, Sara Llufriú, Eugenia Martínez‐Hernández, et al.. (2021). Incidence and Impact of COVID-19 in MS. Neurology Neuroimmunology & Neuroinflammation. 8(2). 28 indexed citations

14.

Català, Martí, Xintong Li, Clara Prats, & Daniel Prieto‐Alhambra. (2021). The impact of prioritisation and dosing intervals on the effects of COVID-19 vaccination in Europe: an agent-based cohort model. Scientific Reports. 11(1). 18812–18812. 10 indexed citations

15.

Català, Martí, David Pino, Père-Joan Cardona, et al.. (2021). Robust estimation of diagnostic rate and real incidence of COVID-19 for European policymakers. PLoS ONE. 16(1). e0243701–e0243701. 23 indexed citations

16.

Seguí, Francesc López, Martí Català, Clara Prats, et al.. (2021). A Cost–Benefit Analysis of COVID-19 Vaccination in Catalonia. Vaccines. 10(1). 59–59. 22 indexed citations

17.

Cardona, Paula, et al.. (2020). Cording Mycobacterium tuberculosis Bacilli Have a Key Role in the Progression towards Active Tuberculosis, Which is Stopped by Previous Immune Response. Microorganisms. 8(2). 228–228. 5 indexed citations

18.

Català, Martí, Clara Prats, Daniel López, Père-Joan Cardona, & Sergio Alonso. (2020). A reaction-diffusion model to understand granulomas formation inside secondary lobule during tuberculosis infection. PLoS ONE. 15(9). e0239289–e0239289. 5 indexed citations

19.

Català, Martí, Jordi Bechini, Cristina Vilaplana, et al.. (2020). Modelling the dynamics of tuberculosis lesions in a virtual lung: Role of the bronchial tree in endogenous reinfection. PLoS Computational Biology. 16(5). e1007772–e1007772. 6 indexed citations

20.

Cardona, Père-Joan, Martí Català, Sergio Alonso, et al.. (2018). Can systems immunology lead tuberculosis eradication?. Current Opinion in Systems Biology. 12. 53–60. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact